Cargando…

Attenuated Psychotic Symptoms in Adolescents With Chronic Cannabis and MDMA Use

OBJECTIVES: Both substance use, on the one hand, and the first signs of psychosis, on the other, commonly begin in adolescence. Adolescents with substance use disorder (SUD) frequently show recreational use of cannabis and 3,4-methylenedioxymethamphetamine (MDMA). When attenuated psychotic symptoms...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiedmann, Melina, Kuitunen-Paul, Sören, Basedow, Lukas A., Roessner, Veit, Golub, Yulia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814345/ https://www.ncbi.nlm.nih.gov/pubmed/35126190 http://dx.doi.org/10.3389/fpsyt.2021.696133

Ejemplares similares

Attenuated psychotic symptoms, substance use and self-reported PTSD in adolescence
por: Basedow, Lukas Andreas, et al.
Publicado: (2023)

Self-reported PTSD is associated with increased use of MDMA in adolescents with substance use disorders
por: Basedow, Lukas Andreas, et al.
Publicado: (2021)

Coping motives mediate the relationship between PTSD and MDMA use in adolescents with substance use disorders
por: Basedow, Lukas Andreas, et al.
Publicado: (2022)

Traumatic Events and Substance Use Disorders in Adolescents
por: Basedow, Lukas A., et al.
Publicado: (2020)

Study protocol: the pragmatic, exploratory DELTA-JU trial of the group-based multimodal DELTA intervention for abstinent adolescents with substance use disorders living in youth welfare institutions
por: Kuitunen-Paul, Sören, et al.
Publicado: (2023)

Comparing self-report and parental report of psychopathologies in adolescents with substance use disorders
por: Kuitunen-Paul, Sören, et al.
Publicado: (2021)

Verbal learning impairment in adolescents with methamphetamine use disorder: a cross-sectional study
por: Basedow, Lukas Andreas, et al.
Publicado: (2021)

DNA methylation changes associated with cannabis use and verbal learning performance in adolescents: an exploratory whole genome methylation study
por: Wiedmann, Melina, et al.
Publicado: (2022)

Diagnostic Accuracy of the Drug Use Disorder Identification Test and Its Short Form, the DUDIT-C, in German Adolescent Psychiatric Patients
por: Basedow, Lukas A., et al.
Publicado: (2021)

Are perinatal measures associated with adolescent mental health? A retrospective exploration with original data from psychiatric cohorts
por: Basedow, Lukas A., et al.
Publicado: (2022)

Differences Between Self-Reported Psychotic Experiences, Clinically Relevant Psychotic Experiences, and Attenuated Psychotic Symptoms in the General Population
por: Moriyama, Tais Silveira, et al.
Publicado: (2019)

MDMA for the treatment of misophonia, a proposal
por: Webb, Jadon, et al.
Publicado: (2022)

A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy
por: Sottile, Robert J., et al.
Publicado: (2022)

DSM-5 Attenuated Psychosis Syndrome in Adolescents Hospitalized With Non-psychotic Psychiatric Disorders
por: Salazar de Pablo, Gonzalo, et al.
Publicado: (2020)

Anxiety Is Associated With DPPIV Alterations in Children With Selective Mutism and Social Anxiety Disorder: A Pilot Study
por: Golub, Yulia, et al.
Publicado: (2021)

A Latent Profile Analysis of Psychotic Experiences, Non-psychotic Symptoms, Suicidal Ideation and Underlying Mechanisms in a Sample of Adolescents From the General Population
por: Langer, Álvaro I., et al.
Publicado: (2022)

Editorial: Psychotic experiences and symptoms in adolescents and young adults from different countries and cultural backgrounds
por: Fekih-Romdhane, Feten, et al.
Publicado: (2023)

Relationship Between Cognitive and Clinical Insight at Different Durations of Untreated Attenuated Psychotic Symptoms in High-Risk Individuals
por: Xu, LiHua, et al.
Publicado: (2021)

The heterogeneity of attenuated and brief limited psychotic symptoms: association of contents with age, sex, country, religion, comorbidities, and functioning
por: Theisen, Christian, et al.
Publicado: (2023)

Symptom Profiles in Psychotic Disorder Not Otherwise Specified
por: Widing, Line, et al.
Publicado: (2020)

A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy
por: Sessa, Ben, et al.
Publicado: (2019)

No Influence of Dopamine System Gene Variations on Acute Effects of MDMA
por: Vizeli, Patrick, et al.
Publicado: (2019)

Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database
por: Makunts, Tigran, et al.
Publicado: (2022)

Relational and Growth Outcomes Following Couples Therapy With MDMA for PTSD
por: Wagner, Anne C., et al.
Publicado: (2021)

Corrigendum: Relationship Between Cognitive and Clinical Insight at Different Durations of Untreated Attenuated Psychotic Symptoms in High-Risk Individuals
por: Xu, LiHua, et al.
Publicado: (2022)

Psychotic Symptoms in Heroin Withdrawal: A Case Report
por: Sharma, Surabhi, et al.
Publicado: (2021)

Family and developmental history of female versus male adolescents with ADHD: diagnosis-specific overlap, few gender/sex differences
por: Waltereit, Johanna, et al.
Publicado: (2023)

Efficacy and Acceptability of Interventions for Attenuated Positive Psychotic Symptoms in Individuals at Clinical High Risk of Psychosis: A Network Meta-Analysis
por: Davies, Cathy, et al.
Publicado: (2018)

A network analysis of anxiety, depressive, and psychotic symptoms and functioning in children and adolescents at clinical high risk for psychosis
por: Lo Buglio, Gabriele, et al.
Publicado: (2022)

MDMA-assisted therapy is associated with a reduction in chronic pain among people with post-traumatic stress disorder
por: Christie, Devon, et al.
Publicado: (2022)

COMTVal158Met polymorphism is associated with ecstasy (MDMA)-induced psychotic symptoms in the Turkish population
por: Aytac, Hasan Mervan, et al.
Publicado: (2022)

Assessing Changes in Symptoms of Depression and Anxiety During Four Weeks of Cannabis Abstinence Among Adolescents
por: Cooke, Megan E., et al.
Publicado: (2021)

Epidemiological Characteristics and Risk Factors of Methamphetamine—Associated Psychotic Symptoms
por: Su, Meng-Fan, et al.
Publicado: (2018)

Evidence for Specific Associations Between Depressive Symptoms, Psychotic Experiences, and Suicidal Ideation in Chilean Adolescents From the General Population
por: Núñez, Daniel, et al.
Publicado: (2021)

Family and Developmental History of Individuals With Autism Spectrum Disorder: Importance of the Clinical Diagnostic Interview for Diagnosis in Adolescents. An Explorative Study
por: Waltereit, Johanna, et al.
Publicado: (2021)

3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review
por: Inouye, Ann, et al.
Publicado: (2022)

Social Defeat, Psychotic Symptoms, and Crime in Young Caribbean Immigrants to Rotterdam
por: Vinkers, David J., et al.
Publicado: (2021)

Measurement Invariance of Psychotic-Like Symptoms as Measured With the Prodromal Questionnaire, Brief Version (PQ-B) in Adolescent and Adult Population Samples
por: Lång, Ulla, et al.
Publicado: (2021)

Sex-Dependent Vulnerability to Cannabis Abuse in Adolescence
por: Rubino, Tiziana, et al.
Publicado: (2015)

The Impact of Aging, Psychotic Symptoms, Medication, and Brain-Derived Neurotrophic Factor on Cognitive Impairment in Japanese Chronic Schizophrenia Patients
por: Atake, Kiyokazu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g414u7tihrh9mheb8pmmo0uu64